MAINTENANCE THERAPY WITH INTERFERON ALFA-2B IN PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA

被引:25
作者
AVILES, A
DIAZMAQUEO, JC
GARCIA, EL
TALAVERA, A
GUZMAN, R
机构
[1] Department of Hematology, Oncology Hospital, National Medical Center, IMSS, México, D.F.
关键词
MALIGNANT LYMPHOMA; NON-HODGKINS LYMPHOMA; INTERFERON; MAINTENANCE THERAPY;
D O I
10.1007/BF00944195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Forty-eight consecutive patients with diffuse large cell lymphoma (DLCL) in complete remission (CR) after conventional chemotherapy were enrolled in a prospective clinical trial. The maintenance therapy was a random either nothing or interferon alfa 2b (IFN) 5.0 MU three times a week for one year. The median duration of CR in the patients treated with IFN has not been reached. After five years 60% of patients remain in CR compared to the control group who had a median CR of 40 months (p < 0.001). Actuarial five-years survival in the IFN treated patients was 88% compared to 42% in the control group (p < 0.001). Maintenance therapy with IFN has been beneficial in patients with DLCL with improvement of duration of CR and survival without the excessive toxicity of most common third generation regimen chemotherapy. We felt that IFN could be explored in most controlled clinical trials in patients with DLCL in CR after conventional chemotherapy.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 13 条
[1]  
[Anonymous], 1982, CANCER, V49, P2112
[2]  
AVILES A, 1990, ARCH INVEST MED, V21, P11
[3]   THE ROLE OF MAINTENANCE THERAPY IN THE TREATMENT OF LARGE-CELL NON-HODGKINS-LYMPHOMA [J].
AVILES, A ;
HUERTA, J ;
ZEPEDA, G ;
GUZMAN, R ;
DIAZMAQUEO, J .
ACTA ONCOLOGICA, 1991, 30 (08) :959-962
[4]  
Cox D.R., 1989, ANAL BINARY DATA, V32
[5]  
FIGLIN RA, 1989, SEMIN HEMATOL, V26, P15
[6]  
GILEWSKI TA, 1990, SEMIN ONCOL, V17, P74
[7]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]   ADJUVANT BACILLUS CALMETTE-GUERIN THERAPY IN NON-HODGKINS MALIGNANT-LYMPHOMAS - LONG-TERM RESULTS OF A RANDOMIZED TRIAL IN A SINGLE INSTITUTION [J].
RAVAUD, A ;
EGHBALI, H ;
TROJANI, M ;
HOERNISIMON, G ;
SOUBEYRAN, P ;
HOERNI, B .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :608-614
[10]   ALPHA-INTERFERON IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES [J].
ROTH, MS ;
FOON, KA .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (05) :871-882